Methyl 3-methyl-1H-indazole-5-carboxylate, 95.0%, 1g

(R)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-(((trifluoromethyl)sulfonyl)oxy)phenyl)propanoate, 98%, 100mg

5-Bromo-1,3-dihydro-2,1-benzothiazole 2,2-dioxide, 97%, 50mg

(S)-3-Dimethylaminopyrrolidine dihydrochloride, 97.0%, 10g

3-[(3-Methoxybenzoyl)aMino]-4-(4-Methyl-1-piperazinyl)benzoic Acid Methyl Ester, 10mg

Methyl 4-oxopiperidine-1-carboxylate, 95.0%, 100mg

5-Bromo-1,7-dimethyl-1H-indazole, 95.0%, 1g

3-Methyl-piperidin-4-one hydrochloride, 97.0%, 1g

TERT-BUTYL 2-(4-AMINOPHENYL)MORPHOLINE-4-CARBOXYLATE, 95.0%, 1g

7-Fluoroquinoline-3-carbonitrile, 95%, 500mg

4-(2-Methylphenyl)pyrrolidin-2-one, 97%, 100mg

Hexcyanoferrate(III) de potassium, min 99 %, technique, 500 g, emballage plastique.

4-[(2-Bromophenyl)methyl]oxan-4-amine hydrochloride, 1g